Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Ophthalmology, Optometry & Ocular Health (Health IT, Devices & Technology)

ELENZA Inc

Parents

*Architects: Ophthalmology, Optometry & Ocular Health (Health IT, Devices & Technology)
*Industry: Virginia
Venture Capital: Series B

Development and technology commercialization of ELENZA's patented Electro-active AutoFocal Intraocular Lens (IOL) to address the cataract extraction market
Electro-active Accommodating IOLs use a proprietary combination of chemistry, electricity, and integrated-circuitry to create smart optics, which will provide patients with the ability to see more naturally and clearly over a range of vision.
ELENZA Closes $24 Million Series B Financing to Fund Development of New Electronic AutoFocal Intraocular Lens 2/8/2011
Roanoke, Virginia
The Carlyle Group (Washington, DC) and Delphi Ventures (Menlo Park, CA), as well as new investors, the Itochu Corporation (Tokyo, Japan) and a strategic corporate investor from the ophthalmic industry.
The lens is controlled by a micro-sized power-cell with an expected 50+ year rechargeable cycle life.
The technology includes an Electro-active switchable optical element that automatically adjusts focusing power electronically, in milliseconds, to maintain constant in focus vision for various working needs and/or light environments.
World's first Electro-active AutoFocal Intraocular Lens (IOL)